Tekla Life Sciences Inves... (HQL)

AI Score

Unlock

13.03

-0.23 (-1.73%)

At close: Mar 04, 2025, 3:59 PM

13.03

0.04%

After-hours: Mar 04, 2025, 07:00 PM EST

Tekla Life Sciences Investors Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY98	FY97	FY96
Net Income	n/a	22.35M	-104.6K	64.53K	123.05K	-70.48K	28.66K	68.56K	-11.91K	40.5K	89.27K	84.64K	77.63M	37.47M	10.19M	-21.67M	60.25M	50.51M	-21.44M	44.76M	7.16M	38.62M	-50.41M	-95.03M	-30.38M	15.19M	21.81M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.86	984.65	n/a	114.1M	-9.3M	26.3M	13.9M	-5.2M	-600K	-3.5M	-4.6M	n/a	n/a	-2.8M	n/a	n/a	-1.3M
Other Non-Cash Items	n/a	-22.35M	104.6K	-64.53K	-123.05K	70.48K	-28.66K	-68.56K	11.91K	-40.5K	-141.77K	-76.12K	-56.53M	-37.47M	-10.19M	21.67M	-60.25M	-50.51M	21.44M	-44.76M	-7.16M	-38.62M	50.41M	95.03M	30.38M	-15.19M	-21.81M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-65.19	948.35	-24.83K	118.3M	1.9M	13M	11.8M	-3.7M	-2.1M	-3.2M	-3.2M	-2.4M	-2.6M	-1.9M	-1.7M	-1.5M	-1.5M
Operating Cash Flow	n/a	n/a	n/a	-0.74	n/a	-0.62	n/a	n/a	n/a	n/a	-52.57K	9.47K	21.11M	118.3M	1.9M	13M	11.8M	-3.7M	-2.1M	-3.2M	-3.2M	-2.4M	-2.6M	-1.9M	-1.7M	-1.5M	-1.5M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.3M	-58.2M	9.8M	8.5M	9.3M	9.6M	10.2M	2M	7.8M	500K
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.3M	-58.2M	9.8M	8.5M	9.3M	9.6M	10.2M	2M	7.8M	500K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-10.88M	-107.1M	-3.8M	n/a	n/a	n/a	71.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-13.96K	-9.44K	-10.23M	-11.2M	-3.6M	-7.6M	-11.8M	-10.6M	-11.1M	-7.3M	-5.7M	-5.9M	-7.2M	-8.1M	-1.6M	-6.3M	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	66.49K	n/a	-10.88M	-107.1M	-3.7M	n/a	n/a	n/a	71.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	52.53K	-9.44K	-21.1M	-118.3M	-7.3M	-7.6M	-11.8M	-10.6M	60.3M	-7.3M	-5.7M	-5.9M	-7.2M	-8.1M	-1.6M	-6.3M	n/a
Net Cash Flow	n/a	32.00	-545	-0.74	n/a	1.12M	n/a	n/a	n/a	n/a	-34.24	35.89	117.00	n/a	-5.4M	5.4M	n/a	n/a	n/a	-700K	-400K	1M	-200K	300K	-1.3M	-100K	-1M
Free Cash Flow	n/a	n/a	n/a	-0.74	n/a	-0.62	n/a	n/a	n/a	n/a	-52.57K	9.47K	21.11M	118.3M	1.9M	13M	11.8M	-3.7M	-2.1M	-3.2M	-3.2M	-2.4M	-2.6M	-1.9M	-1.7M	-1.5M	-1.5M